Evolving treatment paradigms in recurrent and metastatic head and neck squamous cell carcinoma: the emergence of immunotherapy

被引：1
|
作者：
Faraji, Farhoud [1 ]
Cohen, Ezra E. W. [2 ]
Guo, Theresa W. [1 ]
机构：
[1] UC San Diego Hlth, Gleiberman Head & Neck Canc Ctr, Moores Canc Ctr, Dept Otolaryngol Head & Neck Surg, La Jolla, CA USA
[2] UC San Diego Hlth, Dept Internal Med, Gleiberman Head & Neck Canc Ctr, Moores Canc Ctr,Div Hematol Oncol, La Jolla, CA USA
来源：
TRANSLATIONAL CANCER RESEARCH | 2023年 / 12卷 / 05期
关键词：
Immunotherapy; salvage surgery; head and neck squamous cell carcinoma (HNSCC); HUMAN-PAPILLOMAVIRUS; INVESTIGATORS CHOICE; COMORBIDITY INDEX; MUTATIONAL BURDEN; SURGICAL SALVAGE; PD-1; BLOCKADE; CHECKMATE; 141; OPEN-LABEL; SURVIVAL; CANCER;
D O I：
10.21037/tcr-23-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1353 / 1358
页数：6
相关论文
共 50 条
  • [21] Evolving Role of Immunotherapy in Recurrent Metastatic Head and Neck Cancer
    Le, Xiuning
    Ferrarotto, Renata
    Wise-Draper, Trisha
    Gillison, Maura
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (07): : 899 - 906
  • [22] Genomic characteristics and immunotherapy outcomes in patients with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC)
    Park, J. C.
    Cortes, M. Useche
    Durbeck, J.
    Clark, J. R.
    Zhao, Y.
    Saladi, S. V.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S856 - S856
  • [23] Immunotherapy for the treatment of perineural spread in cutaneous head and neck squamous cell carcinoma: Time to rethink treatment paradigms
    Nightingale, James
    Gandhi, Mitesh
    Helena, Jonathan
    Bowman, James
    McGrath, Margaret
    Coward, Jermaine
    Porceddu, Sandro
    Ladwa, Rahul
    Panizza, Benedict
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2022, 44 (05): : 1099 - 1105
  • [24] Tumor Histological Grade and Immunotherapy Response in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Alkhatib, Hosam H.
    Maroun, Christopher A.
    Amin, Neha
    Zhu, Gangcai
    Guller, Meytal
    Herberg, Matthew E.
    Wu, Evan S.
    Seiwert, Tanguy Y.
    Rooper, Lisa M.
    Eisele, David W.
    Fakhry, Carole
    Pardoll, Drew
    Mandal, Rajarsi
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2022, 148 (06) : 540 - 546
  • [25] Correlates of Cetuximab Efficacy in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Previously Treated With Immunotherapy
    Park, Jong Chul
    Ahn, Jong Seok
    Merkin, Ross
    Patel, Manisha
    Wirth, Lori
    Roberts, Thomas J.
    JCO PRECISION ONCOLOGY, 2025, 9
  • [26] PATTERNS AND OUTCOMES OF PALLIATIVE RADIATION THERAPY WITH IMMUNOTHERAPY IN RECURRENT OR METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA
    Roof, Logan
    Yalamanchali, Anirudh
    Buchberger, David
    Campbell, Shauna
    Koyfman, Shlomo
    Woody, Neil
    Silver, Natalie
    Geiger, Jessica
    Yilmaz, Emrullah
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A476 - A476
  • [27] New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
    Alberti, Andrea
    Lorini, Luigi
    Ravanelli, Marco
    Perri, Francesco
    Vinches, Marie
    Rondi, Paolo
    Romani, Chiara
    Bossi, Paolo
    VACCINES, 2022, 10 (06)
  • [28] Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck
    Shin, Dong M.
    Khuri, Fadlo R.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (03): : 443 - 453
  • [29] Therapeutic perspectives for recurrent or metastatic head and neck squamous cell carcinoma
    Gauduchon, Thibault
    Neidhardt, Eve Marie
    Fayette, Jerome
    CURRENT OPINION IN ONCOLOGY, 2025, 37 (03) : 175 - 183
  • [30] Pembrolizumab and afatinib for recurrent or metastatic head and neck squamous cell carcinoma
    Kao, Hsiang-Fong
    Huang, Huai-Cheng
    Liao, Bin-Chi
    Hong, Ruey-Long
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
12345